Tag: chikungunya
Valneva: target date postponed by the FDA in chikungunya – 08/14/2023 at 08:10
(CercleFinance.com) – Valneva announces that the US FDA has postponed, from the end of August to the end of November, its target date for completing the regulatory review of the…
Valneva: postponement for the regulatory review of its chikungunya vaccine candidate – 08/14/2023 at 08:10
(AOF) – Valneva, a company specializing in vaccines, today announced that the United States Food and Drug Administration (FDA) has changed the target date, as part of the Prescription Drug…
Valneva: Valneva drops after FDA delays review date for its Chikungunya vaccine
(Reuters) – Valneva shares fell on the stock market on Monday after the US Food and Drug Administration (FDA) decided to postpone the target date for the regulatory review of…
Valneva: postponement for the regulatory review of its chikungunya vaccine candidate
(AOF) – Valneva, a company specializing in vaccines, today announced that the United States Food and Drug Administration (FDA) has changed the target date, as part of the Prescription Drug…
Valneva: target date postponed by the FDA in chikungunya
(CercleFinance.com) – Valneva announces that the US FDA has postponed, from the end of August to the end of November, its target date for completing the regulatory review of the…
Valneva: file filed in chikungunya in Canada – 05/30/2023 at 07:15
(CercleFinance.com) – Valneva announces that it has filed a marketing authorization (MA) application with Health Canada for its single-shot chikungunya vaccine candidate, VLA1553, for people aged 18 and over. more.…
Valneva: file filed in chikungunya in Canada
(CercleFinance.com) – Valneva announces that it has filed a marketing authorization (MA) application with Health Canada for its single-shot chikungunya vaccine candidate, VLA1553, for people aged 18 and over. more.…
Valneva: FDA grants priority review to chikungunya vaccine candidate – 02/20/2023 at 09:51
(AOF) – Valneva, a company specializing in vaccines, announces today that the American health authority, Food and Drug Administration (FDA), has completed the review of the admissibility of the application…
Valneva: FDA priority review in chikungunya
(CercleFinance.com) – Valneva announces that the US FDA has successfully completed the admissibility review of its marketing authorization application for its single-shot chikungunya vaccine candidate. The United States health authority…
Valneva Completes Submission of Marketing Authorization Application to the FDA for its Chikungunya Vaccine Candidate
By Claude Leguilloux Published on 23/12/2022 at 07:55 Photo credit © Valneva (Boursier.com)…
Valneva: marketing authorization dossier in chikungunya submitted to the FDA – 23/12/2022 at 07:43
(CercleFinance.com) – Valneva announces that it has completed the submission of its marketing authorization application (MA) to the US FDA, for its single-injection vaccine candidate against chikungunya, VLA1553, in people…
Valneva: positive data from a chikungunya vaccine
(CercleFinance.com) – Valneva, a vaccine company, today announced positive antibody persistence data twelve months after vaccination with a single dose of its chikungunya vaccine candidate, VLA1553. Following the announcement of…